Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of the Annual General Meeting in Climeon AB (publ)

The shareholders are hereby called to the Annual General Meeting in Climeon AB (publ), 556846-1643, to be held on Wednesday May 19, 2021 Due to the coronavirus, the Board of Directors has decided that the Annual General Meeting should be conducted without the physical presence of shareholders, representatives or third parties and that the shareholders before the meeting should be able to exercise their voting rights only by post. A presentation by the CEO will be made available at the Company’s website www.climeon.com on May 19, 2021. Information on the resolutions passed at the meeting

Liberty Global has selected Teleste’s Distributed Access solution

Turku, Finland –  15 April 2021 –  Teleste has announced that Liberty Global (NASDAQ: LBTYA, LBTYB and LBTYK), one of the world’s leading converged video, broadband and communications companies, will trial Teleste’s Distributed Access Architecture to support their GIGAbit network, meaning customers will benefit from increased reliability and capacity thanks to the new DOCSIS technology. Already used successfully in Coventry and Warrington in the UK, Distributed Access Architecture (DAA) is now being rolled out in Baguley, UK. DAA is a new way of building DOCSIS networks and is being

Epiroc awards recognize mining automation and diesel-to-battery conversion

Stockholm, Sweden: Epiroc AB, a leading productivity and sustainability partner for the mining and infrastructure industries, is recognizing mining automation and battery electrification with three annual awards.The United in Performance Award honors exceptional customer collaboration. This award is presented to Rodrigo Izzo, Carlos Valencia, Pedro Debia and Luis Vera of Epiroc Chile, as well as to mining company Antofagasta Minerals’ team at its Los Pelambres copper mine. Through close collaboration, they made two Pit Viper 351 drilling rigs fully autonomous, which has strengthened safety

Crown Energy has relinquished its interest in Block P Licence, Equatorial Guinea

INSIDE INFORMATION: Crown Energy AB (publ) ("Crown Energy", "The Company") has relinquished its 5 per cent equity interest (6.25 per cent paying interest) interest in Block P Licence, Equatorial Guinea. After some time and careful consideration, the Board of Directors has decided that the economic prospects for the project does not live up to the risk/reward expectations of Crown Energy.The Company, in accordance with ongoing policy of prudent financial asset management, has relinquished its interest in Block P, Equatorial Guinea. This interest now reverts to the other members of the Block

Notice to attend the annual general meeting in Speqta AB (Plc)

The shareholders of Speqta AB (publ), reg.no. 556710-8757 (the ”Company”), are hereby given notice to attend the Annual General Meeting on Tuesday 18 May 2021. In order to counteract the spreading of the corona virus, the board of directors of the Company has decided, in accordance with Sections 20 and 22 of the Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other associations (Sw. lagen (2020:198) om tillfälliga undantag för att underlätta genomförandet av bolags- och föreningsstämmor), that the annual general meeting shall be held

Espiria recruits new fund manager with expertise in sustainable investments

Espiria recruits Huizi Zeng, who with a solid background in impact investments will further develop the fund management related to the Sustainable Development Goals (SDG). Huizi Zeng has 15 years of experience in fund investment, research, and corporate finance advisory, most recently from the position as Impact Investment Advisor at China Alliance of Social Value Investment and as a consultant at her own firm. Prior to that, she held roles at Beringer Finance and Willis Towers Watson, as well as East Capital, where she was an analyst from 2011 to 2016. Huizi Zeng holds a B.A. in

Sedana Medical publishes its Annual Report 2020

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that its Annual Report for 2020 has been published.Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that its Annual Report for 2020 has been published and is available on www.sedanamedical.com/investors . The annual report can also be ordered from the company and distributed by post to the shareholders who so request. ***** For additional information, please contact:Christer Ahlberg, President and CEO, +46 70 675 33 30Susanne Andersson, CFO, +46 73 066 89 04

OrganoClick launches OrganoTex® ShoeCare

For several years, OrganoClick has been supplying PFAS-free and biodegradable OrganoTex® textile waterproofing for impregnation of functional clothing. OrganoClick is now also launching OrganoTex® shoe care for the treatment and impregnation of shoes.OrganoTex® ShoeCare series consists of a biodegradable universal spray for shoes and boots in all types of materials as well as a 100% biobased and biodegradable water-repellent and caring leather wax. Most resellers of OrganoTex® textile waterproofing, such as Naturkompaniet, will now also start selling OrganoTex® ShoeCare. “We have been

Midsummer's Annual Report for 2020 is published

The Midsummer Annual Report for 2020 is now available in Swedish on the www.midsummer.se web site and as attached in this press release.Links to images and other press material: Press - Midsummer . For additional information contact::Peter KarasziHead of Communications, MidsummerEmail: peter.karaszi@midsummer.seTel: + 46 76 200 14 29 About Midsummer Midsummer is a leading developer and supplier of advanced solar energy technology solutions for the production and installation of thin film solar panels. Its business offering includes

Issue and repurchase of class C shares

Tobii AB (publ) announces that the company has resolved to issue and immediately thereafter repurchase 900,000 class C shares. The shares are issued and repurchased in accordance with the long-term incentive program, LTI 2020, which was adopted by the annual general meeting on 12 May 2020. Carnegie Investment Bank AB (publ) subscribes for the entire issue of new class C shares at a subscription price corresponding to the share’s quota value amounting to approximately SEK 0.007. The entire issue of class C shares will thereafter be repurchased by Tobii for the same price per share. The

Liberty Global has selected Teleste’s Distributed Access solution

TELESTE CORPORATION     INVESTOR NEWS     15.4.2021   AT 9:30 EET LIBERTY GLOBAL HAS SELECTED TELESTE´S DISTRIBUTED ACCESS SOLUTION Teleste has announced that Liberty Global, one of the world’s leading converged video, broadband and communications companies, will trial Teleste’s Distributed Access Architecture to support their GIGAbit network, meaning customers will benefit from increased reliability and capacity thanks to the new DOCSIS technology. Already used successfully in Coventry and Warrington in the UK, Distributed Access Architecture (DAA) is now being rolled out in

Adverty announces collaboration with Oracle Moat to enhance measurement across its in-game advertising platform

Leading in-game advertising platform, Adverty, today announced a collaboration with Oracle Moat, to provide enhanced measurement and verification for in-game ad traffic and impressions. Oracle Moat’s iconic verification solution will give publishers, agencies and advertisers access to trusted third-party measurement for in-game ad campaigns.Adverty’s mission is to deliver seamless advertising which connects brands and audiences through its revolutionary technology, built specifically for gaming, at a time when more than three billion people around the world play video games regularly.

Aušra Antanavičienė has been appointed Vice President, Human Resources, and a member of the Management Team at Peikko Group

Aušra Antanavičienė has been appointed Vice President, Human Resources, and a member of the Management Team of Peikko Group. Aušra will begin her new role on August 1, 2021. Peikko’s current Vice President, Human Resources, Kjell-Ole Gjestemoen will retire by the end of 2021. Aušra Antanavičienė has the strong, versatile experience of HR leadership roles at international organizations. She has worked at Peikko since 2017 as HR Manager for Peikko Lithuania and as Learning and Development Manager at Peikko Group. Prior to joining Peikko she held various HR positions in Nordic

Nilar intends to list the company's shares on Nasdaq First North Premier Growth Market

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, CANADA, JAPAN, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE IN ACCORDANCE WITH APPLICABLE LAW. Nilar International AB (publ) (“Nilar” or the “Company”), an innovative developer of batteries and electrical energy storage systems for stationary applications, today announces the intention to list the

Alzinova publishes the Annual Report for 2021

The Board of Directors and the Chief Executive Officer of Alzinova AB (publ) hereby present the Annual Report of the financial year 2020.The Annual Report, which is attached in the press release, can also be downloaded from the company’s Swedish website, www.alzinova.com/investors/financial-reports/   For more information, please contact:Kristina Torfgård, CEOtel: +46 708 46 79 75E-mail: kristina.torfgard@alzinova.com Håkan Skogström, CFOtel: +46 705 85 08 59E-mail: hakan.skogstrom@alzinova.com   About Alzinova ABAlzinova AB is a Swedish biopharma company

Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy

Lund, Sweden, April 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to the expansion of Alligator’s proprietary patient specific immunotherapy Neo-X-Prime™ by incorporating MacroGenics’ proprietary DART[®] and TRIDENT[®] multi-specific platforms against two undisclosed targets.Under the

Keliber Upgraded the Process and Supplemented the EIA Report of the Kokkola Plant

The process of Keliber’s lithium chemical plant in Kokkola has been developed since the assessment report of the environmental impact assessment (EIA) procedure was completed on 6 March 2020. The company has now supplemented the EIA report to reflect the current project plan. The process changes apply to the treatment of effluent and analcime sand, which is a by-product created in the process. A supplemented EIA report was submitted to the ELY Centre of Southern Ostrobothnia on 31 March 2021. ELY will issue a supplemented reasoned conclusion on the report.According to the original plan,

Catella expands within Hospitality capital markets

Gustav Correll Bjørn joins Catella Corporate Finance capital markets team in Denmark with the aim of providing capital and liquidity to the Nordic hospitality sector addressing the current recapitalization needs, by introducing capital solutions and advisory services to the sector.The aim is to help current and future actors in the sector via sustainable and sound fresh capital solutions. In the long term, the platform will become a natural extension of Catella’s market-leading Corporate Finance operation, providing debt advisory and M&A services to the hospitality sector and the growth in

Invitation to presentation of BioArctic’s Interim Report for the period January - March 2021 on April 21 at 9.30 a.m. CET

Stockholm, Sweden, April 15, 2021 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will publish the company’s Interim Report for the period January – March 2021 on Wednesday, April 21, 2021, at 08:00 a.m. CET.In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on April 21, at 09:30 CET, where Gunilla Osswald, CEO, and Jan Mattsson, CFO, will present BioArctic and comment on the Interim Report for the period January – March 2021, followed by a Q&A-session. To attend, please dial-in at one of the numbers below,

Notice of annual general meeting in BONESUPPORT HOLDING AB

The shareholders in BONESUPPORT HOLDING AB (publ), Reg. No. 556802-2171, are hereby invited to attend the annual general meeting (Sw. årsstämma) to be held on Thursday 20 May 2021. The board of directors has, in light of the ongoing Corona pandemic, decided that the annual general meeting should be conducted by way of postal vote pursuant to temporary legislation being in effect in 2021. This means that the annual general meeting will be held without the physical presence of shareholders, representatives or third parties. The shareholders will therefore only be able to exercise their

Valio’s climate targets granted Science Based Targets certification -  Valio’s goal is to reset milk’s carbon footprint to zero by 2035

In 2020, Valio set science-based targets to reduce greenhouse gas emissions, and now, they have been accepted by the Science Based Targets initiative.* Valio is committed to limit the environmental impact of its production chain to an increase of no more than 1.5 degrees Celsius, in accordance with the Paris Climate Agreement. Dairy farm greenhouse emissions are monitored with the CARBO® environmental calculator. Over 600 dairy farms have already calculated their carbon footprint as a base for emissions reductions in the future.Set in summer 2020, Valio’s emission reduction targets to stop

Invitation to presentation of Midsona’s interim report on 29 April 2021

Midsona will publish its interim report January-March 2021 on 29 April 2021 at 8am CET. A presentation of the report will be held the same day at 11am CET via telephone conference or audio cast.Midsona invites investors, financial analysts, and media to a presentation where Managing Director and CEO Peter Åsberg and CFO Max Bokander will comment on the report. The presentation will be held at 11am CET and can be followed via telephone conference or audiocast. The report will be published at 8am CET and will be available at https://www.midsona.com/en/investors/reports/ The presentation

Nurminen Logistics expands its Asian routes to Yokohama, Japan, and opens two new destinations in China

Nurminen's train service, which started in 2018, has transported cargo from Helsinki and Narvik in Norway to various destinations in China and back. Due to enormously increased demand, the company is now expanding its rail routes to Japan. The company announced the Japan route opening at the international exhibition TransRussia in Moscow on April 12.The last train from Finland to Japan was more than 30 years ago. Nurminen Logistics train to Yokohama departs from Helsinki on April 15.The journey of more than 10,000 kilometers starts by train from Helsinki to Vostochny port in Nakhodka and

Nature article presents impact and importance of epithelial barrier damage on a range of common diseases.

STOCKHOLM, SWEDEN, — April 15, 2021 – SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a  groundbreaking article presenting the “epithelial barrier hypothesis” in Nature Reviews Immunology. The article was written by Professor Cezmi Akdis at the Swiss institute of Allergy and Asthma Research (SIAF). Prof. Akdis is the key research collaborator in SciBase’s product development for skin barrier assessment. The article presents the background for the steep increase in allergic diseases

There are no items matching the current filter
There are no more items matching the current filter
Back to top